Nils Hoem, Martin Maduas, Francis Lunger, and Philip Petraglia | GenomeWeb

MDS Pharma has appointed Nils Hoem as director of pharmacokinetics/pharmacodynamics in Europe, the company said last week.

Hoem will be responsible for managing a team of approximately 15 scientists located in MDS’ European clinical pharmacology units. Prior to joining MDS, Hoem ran his own business, Hoem Pharma Consulting. He was also employed by Smerud Medical Research Group and the University of Oslo. He holds a PhD in clinical pharmacokinetics and pharmacodynamics from the University of Oslo.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.